Literature DB >> 8473490

Cytokine patterns in the pathogenesis of human leishmaniasis.

C Pirmez1, M Yamamura, K Uyemura, M Paes-Oliveira, F Conceição-Silva, R L Modlin.   

Abstract

The host response to infection appears to be regulated by specific patterns of local cytokine production. In the mouse, resistance to many pathogens including Leishmania is associated with a TH1 cytokine profile, IL-2 and IFN-gamma; whereas susceptibility to infection is associated with production of TH2 cytokines, IL-4, IL-5, and IL-10. To determine the cytokine patterns of the local immune response to Leishmania infection in humans, we used the polymerase chain reaction to compare cytokine mRNAs in biopsy specimens of American cutaneous leishmaniasis. In localized cutaneous leishmaniasis and the Montenegro delayed-type hypersensitivity reaction, type 1 cytokine mRNAs such as IL-2, IFN-gamma, and lymphotoxin were relatively predominant. In the chronic and destructive mucocutaneous form of leishmaniasis, there was a mixture of type 1 and type 2 cytokines, with a striking abundance of IL-4 mRNA in lesions. These results suggest that clinical course of infection with Leishmania braziliensis in man is associated with specific local patterns of cytokine production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473490      PMCID: PMC288111          DOI: 10.1172/JCI116341

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Cytokine patterns of immunologically mediated tissue damage.

Authors:  M Yamamura; X H Wang; J D Ohmen; K Uyemura; T H Rea; B R Bloom; R L Modlin
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

2.  Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.

Authors:  M D Sadick; R M Locksley; C Tubbs; H V Raff
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  Antibodies to laminin in American cutaneous leishmaniasis.

Authors:  J L Avila; M Rojas; M Rieber
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

4.  Circulating immune complexes and anti-IgG antibodies in mucocutaneous leishmaniasis.

Authors:  P Desjeux; F Santoro; D Afchain; M Loyens; A Capron
Journal:  Am J Trop Med Hyg       Date:  1980-03       Impact factor: 2.345

5.  Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis.

Authors:  M Castés; A Agnelli; A J Rondón
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

6.  In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor.

Authors:  R L Modlin; F M Hofman; D A Horwitz; L A Husmann; S Gillis; C R Taylor; T H Rea
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

7.  Susceptibility of inbred mice to Leishmania tropica infection: correlation of susceptibility with in vitro defective macrophage microbicidal activities.

Authors:  C A Nacy; A H Fortier; M G Pappas; R R Henry
Journal:  Cell Immunol       Date:  1983-04-15       Impact factor: 4.868

8.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Authors:  H W Murray; B Y Rubin; C D Rothermel
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

9.  Characterization of the cellular immune response in American cutaneous leishmaniasis.

Authors:  M Castes; A Agnelli; O Verde; A J Rondón
Journal:  Clin Immunol Immunopathol       Date:  1983-05

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  104 in total

1.  Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy.

Authors:  N Van Damme; M De Vos; D Baeten; P Demetter; H Mielants; G Verbruggen; C Cuvelier; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

2.  Virulent or avirulent (dhfr-ts-) Leishmania major elicit predominantly a type-1 cytokine response by human cells in vitro.

Authors:  C Brodskyn; S M Beverley; R G Titus
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 3.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

Review 4.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

5.  Th1/Th2 cytokine profile in patients coinfected with HIV and Leishmania in Brazil.

Authors:  Maria Zilma Andrade Rodrigues; Maria Fernanda Rios Grassi; Sanjay Mehta; Xing-Quan Zhang; Luana Leandro Gois; Robert T Schooley; Roberto Badaro
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

6.  Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis.

Authors:  Diego L Costa; Luiz H Guimarães; Thiago M Cardoso; Adriano Queiroz; Ednaldo Lago; Ana M Roselino; Olívia Bacellar; Edgar M Carvalho; João S Silva
Journal:  Hum Immunol       Date:  2013-08-28       Impact factor: 2.850

7.  Th1 immune response promotes severe bone resorption caused by Porphyromonas gingivalis.

Authors:  Philip Stashenko; Reginaldo B Gonçalves; Brad Lipkin; Alexander Ficarelli; Hajime Sasaki; Antonio Campos-Neto
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

8.  Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression.

Authors:  A C Maretti-Mira; M P de Oliveira-Neto; A M Da-Cruz; M P de Oliveira; N Craft; C Pirmez
Journal:  Clin Exp Immunol       Date:  2010-11-22       Impact factor: 4.330

9.  Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials.

Authors:  Anne Maurer-Cecchini; Saskia Decuypere; François Chappuis; Coralie Alexandrenne; Simonne De Doncker; Marleen Boelaert; Jean-Claude Dujardin; Louis Loutan; Jean-Michel Dayer; Gianfranco Tulliano; Jorge Arevalo; Alexandro Llanos-Cuentas; Carlo Chizzolini
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

10.  Characterization of a Leishmania tropica antigen that detects immune responses in Desert Storm viscerotropic leishmaniasis patients.

Authors:  D C Dillon; C H Day; J A Whittle; A J Magill; S G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.